Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Respiratory Monitoring Devices Market by Monitoring device (Pulse Oximeters, Capnography, Spirometers, Polysomnography (Psg), Peak Flow Meters, Gas Analyzers, Others), by Indication (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Sleep Apnoea, Infectious Disease) and by End User . (Hospitals, Ambulatory Surgical Centers, Specialty Clinics): Global Opportunity Analysis and Industry Forecast, 2023-2032

A10367

Pages: NA

Charts: NA

Tables: NA

Respiratory Monitoring Devices Market Outlook - 2027

Respiratory monitoring is a constituent of polysomnography (PSG), it helps to detect sleep-related breathing disorders related with diurnal movement disorders. Polysomnography (PSG) is help to receive data on respiration and sleeping patterns. Respiratory monitoring device used to ensure airway effectiveness and sufficient gas exchange. Most commonly used device such as “RespiraSense” is a continuous and accurately measures respiratory rate by measuring the Mechanics of Respiration. The main three components for  monitoring respiratory rate during sleep such as detection of airflow, detection of respiratory effort, and measurement of arterial oxygen saturation (SaO2). Healthcare industries in the respiratory monitoring devices market are now focusing on developing PSG sensors that provide information to healthcare providers. Signal analysis and machine learning are major factors enhancing the implementation of PSG in the healthcare industry. Various types of respiratory monitoring devices are available in the respiratory monitoring device market such as Pulse Oximeters, Capnography, Spirometers, Polysomnography (Psg), Peak Flow Meters, Gas Analyzers etc., out of this increasing patient demand for peak flow meter and pulse oximeter, both this device majorly drive the market growth globally.

COVID-19 Scenario Analysis:

To take care of infected population the demand for medical supplies is increasing. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With rise in number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both from healthcare professionals and civil population for precautionary measures. Manufacturers of these products have a chance to capitalize this increased demand of medical supplies to ensure adequate and continuous supply of personal protective equipment in the market.

Ongoing spread of COVID-19 affect positively on healthcare industry. Likewise, it affect the respiratory monitoring system market positively.  During this situation healthcare professional use Positive end-expiratory pressure (PEEP), which helps to maximize in lung compliance and reduces in dead space ventilation of coronavirus infected patient. It is the great opportunity to the major market player to come up with the advanced technologies and devices which help in reduce the rate of coronavirus infected people and generate more revenue to boost the market growth.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

Asthma is one of the largest contributors in this market, which affecting children, adults, and elderly people which rises the demand for Peak flow meters and now this device is most dominating product segment in the respiratory monitoring market during the forecast period .The home care segment is anticipated to achieve significant respiratory monitoring devices market share, attributed to rising in the number of market players who receiving Food and Drug Administration (FDA) approval for home use respiratory monitoring devices. According to Global Asthma report, in 2018, chronic respiratory diseases affect more than 1 billion people.

Globally North America has dominated the respiratory monitoring market owing to the rising incidence of respiratory disorders. Increasing per capita healthcare expenditure, reduction in the unemployment rate and growing number of smoker’s population. On the other hand Europe, anticipated to the second largest market share due to the increasing geriatric population and rising awareness about advanced therapies amongst the people. Whereas, Asia-Pacific expected to contribute highest growth rate due to the increasing geriatric population, rising respiratory disorders and growing demand for respiratory devices. 

The factor such as rising investment in healthcare expenditure, growing expansion of advance technologies, availability of low cost of respiratory monitoring devices, rising geriatric population across the globe, Increasing chronic obstructive pulmonary disease patients (COPD), Asthma, and tuberculosis, high incidence of tobacco smoking and respiratory diseases, are majorly drive the respiratory monitoring device market. The factor that hinder the growth of market such as high cost of COPD treatment and existing technologies. Major opportunities available in the respiratory monitoring device market across the globe such as reduce the cost of product as well as treatment, development of new technologies etc. 

New product launches to flourish the market:

Manufacturers have been focusing on producing new products for specific applications as there are varying demands based on the utilization. Leading respiratory monitoring devices market players have determined how improved accuracy can be influential in many applications. The expansion of automated nucleic acid isolation and purification solutions by major market players allows a faster, cleaner, and more consistent nucleic acid extraction process. In 2019, Phillips N.V. has launched new devices such as “noninvasive high frequency chest wall oscillation” (HFCWO), which redefine non-invasive secretion clearance which helps to use in hospital and at home to improve patient lives. This device helps clinicians to use this new tools to enhance therapy efficacy. In 2019, “GE Healthcare” has launched “CARESCAPE Respiratory Modules” and “Airway Gas Option” is a respiratory accessories which is used for monitoring patient and ventilators to measure respiratory gases such as oxygen and carbon dioxide, anesthesia, and breathing characteristics in adults, pediatric, and neonatal patients. In 2019,”Medtronic” has introduce new system such as “NellcorTM” (PM1000N). This system has easy to use and access patient status related to oxygenation and respiration. In 2019,”Medtronic” has introduce new ventilation solution for tiniest of patient such as “Babylog VN500”. In 2019, “Masimo” has launched the “MightSat Rx”. It is a finger pulse oximeter that can be used at home.

 Key benefits of the report:

  • This study presents the analytical depiction of the global respiratory monitoring devices market industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the respiratory monitoring devices market share.
  • The current market is quantitatively analyzed to highlight the global respiratory monitoring devices market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed global respiratory monitoring devices market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the Respiratory Monitoring Devices Market research report:

  • Who are the leading market players active in the respiratory monitoring devices market?
  • What are the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that will help in taking further strategic steps?

Key Market Segments

  • By Monitoring device
    • Pulse Oximeters
    • Capnography
    • Spirometers
    • Polysomnography (Psg)
    • Peak Flow Meters
    • Gas Analyzers
    • Others
  • By Indication
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Asthma
    • Sleep Apnoea
    • Infectious Disease
  • By End User .
    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Clinics
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • Vyaire Medical Inc.
  • Masimo
  • Medtronic
  • Nihon Kohden Corporation
  • MGC Diagnostics Corporation
  • Drägerwerk AG and Co. KGaA
  • GE Healthcare
  • Koninklijke Philips N.V
  • Welch Allyn, Inc.
  • Smiths Medical plc.
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: RESPIRATORY MONITORING DEVICES MARKET, BY MONITORING DEVICE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Monitoring Device

    • 4.2. Pulse Oximeters

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Capnography

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Spirometers

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Polysomnography (Psg)

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Peak Flow Meters

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. Gas Analyzers

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

    • 4.8. Others

      • 4.8.1. Key Market Trends, Growth Factors and Opportunities

      • 4.8.2. Market Size and Forecast, By Region

      • 4.8.3. Market Share Analysis, By Country

  • CHAPTER 5: RESPIRATORY MONITORING DEVICES MARKET, BY INDICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Indication

    • 5.2. Chronic Obstructive Pulmonary Disease (COPD)

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Asthma

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Sleep Apnoea

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Infectious Disease

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: RESPIRATORY MONITORING DEVICES MARKET, BY END USER .

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User .

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Ambulatory Surgical Centers

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Specialty Clinics

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: RESPIRATORY MONITORING DEVICES MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Monitoring Device

      • 7.2.3. Market Size and Forecast, By Indication

      • 7.2.4. Market Size and Forecast, By End User .

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Respiratory Monitoring Devices Market

        • 7.2.6.1. Market Size and Forecast, By Monitoring Device
        • 7.2.6.2. Market Size and Forecast, By Indication
        • 7.2.6.3. Market Size and Forecast, By End User .
      • 7.2.7. Canada Respiratory Monitoring Devices Market

        • 7.2.7.1. Market Size and Forecast, By Monitoring Device
        • 7.2.7.2. Market Size and Forecast, By Indication
        • 7.2.7.3. Market Size and Forecast, By End User .
      • 7.2.8. Mexico Respiratory Monitoring Devices Market

        • 7.2.8.1. Market Size and Forecast, By Monitoring Device
        • 7.2.8.2. Market Size and Forecast, By Indication
        • 7.2.8.3. Market Size and Forecast, By End User .
    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Monitoring Device

      • 7.3.3. Market Size and Forecast, By Indication

      • 7.3.4. Market Size and Forecast, By End User .

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Respiratory Monitoring Devices Market

        • 7.3.6.1. Market Size and Forecast, By Monitoring Device
        • 7.3.6.2. Market Size and Forecast, By Indication
        • 7.3.6.3. Market Size and Forecast, By End User .
      • 7.3.7. Germany Respiratory Monitoring Devices Market

        • 7.3.7.1. Market Size and Forecast, By Monitoring Device
        • 7.3.7.2. Market Size and Forecast, By Indication
        • 7.3.7.3. Market Size and Forecast, By End User .
      • 7.3.8. Italy Respiratory Monitoring Devices Market

        • 7.3.8.1. Market Size and Forecast, By Monitoring Device
        • 7.3.8.2. Market Size and Forecast, By Indication
        • 7.3.8.3. Market Size and Forecast, By End User .
      • 7.3.9. Spain Respiratory Monitoring Devices Market

        • 7.3.9.1. Market Size and Forecast, By Monitoring Device
        • 7.3.9.2. Market Size and Forecast, By Indication
        • 7.3.9.3. Market Size and Forecast, By End User .
      • 7.3.10. UK Respiratory Monitoring Devices Market

        • 7.3.10.1. Market Size and Forecast, By Monitoring Device
        • 7.3.10.2. Market Size and Forecast, By Indication
        • 7.3.10.3. Market Size and Forecast, By End User .
      • 7.3.11. Russia Respiratory Monitoring Devices Market

        • 7.3.11.1. Market Size and Forecast, By Monitoring Device
        • 7.3.11.2. Market Size and Forecast, By Indication
        • 7.3.11.3. Market Size and Forecast, By End User .
      • 7.3.12. Rest Of Europe Respiratory Monitoring Devices Market

        • 7.3.12.1. Market Size and Forecast, By Monitoring Device
        • 7.3.12.2. Market Size and Forecast, By Indication
        • 7.3.12.3. Market Size and Forecast, By End User .
    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Monitoring Device

      • 7.4.3. Market Size and Forecast, By Indication

      • 7.4.4. Market Size and Forecast, By End User .

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Respiratory Monitoring Devices Market

        • 7.4.6.1. Market Size and Forecast, By Monitoring Device
        • 7.4.6.2. Market Size and Forecast, By Indication
        • 7.4.6.3. Market Size and Forecast, By End User .
      • 7.4.7. Japan Respiratory Monitoring Devices Market

        • 7.4.7.1. Market Size and Forecast, By Monitoring Device
        • 7.4.7.2. Market Size and Forecast, By Indication
        • 7.4.7.3. Market Size and Forecast, By End User .
      • 7.4.8. India Respiratory Monitoring Devices Market

        • 7.4.8.1. Market Size and Forecast, By Monitoring Device
        • 7.4.8.2. Market Size and Forecast, By Indication
        • 7.4.8.3. Market Size and Forecast, By End User .
      • 7.4.9. South Korea Respiratory Monitoring Devices Market

        • 7.4.9.1. Market Size and Forecast, By Monitoring Device
        • 7.4.9.2. Market Size and Forecast, By Indication
        • 7.4.9.3. Market Size and Forecast, By End User .
      • 7.4.10. Australia Respiratory Monitoring Devices Market

        • 7.4.10.1. Market Size and Forecast, By Monitoring Device
        • 7.4.10.2. Market Size and Forecast, By Indication
        • 7.4.10.3. Market Size and Forecast, By End User .
      • 7.4.11. Thailand Respiratory Monitoring Devices Market

        • 7.4.11.1. Market Size and Forecast, By Monitoring Device
        • 7.4.11.2. Market Size and Forecast, By Indication
        • 7.4.11.3. Market Size and Forecast, By End User .
      • 7.4.12. Malaysia Respiratory Monitoring Devices Market

        • 7.4.12.1. Market Size and Forecast, By Monitoring Device
        • 7.4.12.2. Market Size and Forecast, By Indication
        • 7.4.12.3. Market Size and Forecast, By End User .
      • 7.4.13. Indonesia Respiratory Monitoring Devices Market

        • 7.4.13.1. Market Size and Forecast, By Monitoring Device
        • 7.4.13.2. Market Size and Forecast, By Indication
        • 7.4.13.3. Market Size and Forecast, By End User .
      • 7.4.14. Rest of Asia Pacific Respiratory Monitoring Devices Market

        • 7.4.14.1. Market Size and Forecast, By Monitoring Device
        • 7.4.14.2. Market Size and Forecast, By Indication
        • 7.4.14.3. Market Size and Forecast, By End User .
    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Monitoring Device

      • 7.5.3. Market Size and Forecast, By Indication

      • 7.5.4. Market Size and Forecast, By End User .

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Respiratory Monitoring Devices Market

        • 7.5.6.1. Market Size and Forecast, By Monitoring Device
        • 7.5.6.2. Market Size and Forecast, By Indication
        • 7.5.6.3. Market Size and Forecast, By End User .
      • 7.5.7. South Africa Respiratory Monitoring Devices Market

        • 7.5.7.1. Market Size and Forecast, By Monitoring Device
        • 7.5.7.2. Market Size and Forecast, By Indication
        • 7.5.7.3. Market Size and Forecast, By End User .
      • 7.5.8. Saudi Arabia Respiratory Monitoring Devices Market

        • 7.5.8.1. Market Size and Forecast, By Monitoring Device
        • 7.5.8.2. Market Size and Forecast, By Indication
        • 7.5.8.3. Market Size and Forecast, By End User .
      • 7.5.9. UAE Respiratory Monitoring Devices Market

        • 7.5.9.1. Market Size and Forecast, By Monitoring Device
        • 7.5.9.2. Market Size and Forecast, By Indication
        • 7.5.9.3. Market Size and Forecast, By End User .
      • 7.5.10. Argentina Respiratory Monitoring Devices Market

        • 7.5.10.1. Market Size and Forecast, By Monitoring Device
        • 7.5.10.2. Market Size and Forecast, By Indication
        • 7.5.10.3. Market Size and Forecast, By End User .
      • 7.5.11. Rest of LAMEA Respiratory Monitoring Devices Market

        • 7.5.11.1. Market Size and Forecast, By Monitoring Device
        • 7.5.11.2. Market Size and Forecast, By Indication
        • 7.5.11.3. Market Size and Forecast, By End User .
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Koninklijke Philips N.V

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. GE Healthcare

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Medtronic

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Smiths Medical Plc.

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Drägerwerk AG And Co. KGaA

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Welch Allyn, Inc.

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Masimo

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. MGC Diagnostics Corporation

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Vyaire Medical Inc.

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Nihon Kohden Corporation

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL RESPIRATORY MONITORING DEVICES MARKET, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL RESPIRATORY MONITORING DEVICES MARKET FOR PULSE OXIMETERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL RESPIRATORY MONITORING DEVICES MARKET FOR CAPNOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL RESPIRATORY MONITORING DEVICES MARKET FOR SPIROMETERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL RESPIRATORY MONITORING DEVICES MARKET FOR POLYSOMNOGRAPHY (PSG), BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL RESPIRATORY MONITORING DEVICES MARKET FOR PEAK FLOW METERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL RESPIRATORY MONITORING DEVICES MARKET FOR GAS ANALYZERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL RESPIRATORY MONITORING DEVICES MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL RESPIRATORY MONITORING DEVICES MARKET, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL RESPIRATORY MONITORING DEVICES MARKET FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL RESPIRATORY MONITORING DEVICES MARKET FOR ASTHMA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL RESPIRATORY MONITORING DEVICES MARKET FOR SLEEP APNOEA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL RESPIRATORY MONITORING DEVICES MARKET FOR INFECTIOUS DISEASE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL RESPIRATORY MONITORING DEVICES MARKET, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL RESPIRATORY MONITORING DEVICES MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL RESPIRATORY MONITORING DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. GLOBAL RESPIRATORY MONITORING DEVICES MARKET FOR SPECIALTY CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. GLOBAL RESPIRATORY MONITORING DEVICES MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA RESPIRATORY MONITORING DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. NORTH AMERICA RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 21. NORTH AMERICA RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 22. NORTH AMERICA RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 23. U.S. RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 24. U.S. RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 25. U.S. RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 26. CANADA RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 27. CANADA RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 28. CANADA RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 29. MEXICO RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 30. MEXICO RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 31. MEXICO RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 32. EUROPE RESPIRATORY MONITORING DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 33. EUROPE RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 34. EUROPE RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 35. EUROPE RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 36. FRANCE RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 37. FRANCE RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 38. FRANCE RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 39. GERMANY RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 40. GERMANY RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 41. GERMANY RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 42. ITALY RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 43. ITALY RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 44. ITALY RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 45. SPAIN RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 46. SPAIN RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 47. SPAIN RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 48. UK RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 49. UK RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 50. UK RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 51. RUSSIA RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 52. RUSSIA RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 53. RUSSIA RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 54. REST OF EUROPE RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 55. REST OF EUROPE RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 56. REST OF EUROPE RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 57. ASIA-PACIFIC RESPIRATORY MONITORING DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 58. ASIA-PACIFIC RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 59. ASIA-PACIFIC RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 60. ASIA-PACIFIC RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 61. CHINA RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 62. CHINA RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 63. CHINA RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 64. JAPAN RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 65. JAPAN RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 66. JAPAN RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 67. INDIA RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 68. INDIA RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 69. INDIA RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 70. SOUTH KOREA RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 71. SOUTH KOREA RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 72. SOUTH KOREA RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 73. AUSTRALIA RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 74. AUSTRALIA RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 75. AUSTRALIA RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 76. THAILAND RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 77. THAILAND RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 78. THAILAND RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 79. MALAYSIA RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 80. MALAYSIA RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 81. MALAYSIA RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 82. INDONESIA RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 83. INDONESIA RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 84. INDONESIA RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 85. REST OF ASIA PACIFIC RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 86. REST OF ASIA PACIFIC RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 87. REST OF ASIA PACIFIC RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 88. LAMEA RESPIRATORY MONITORING DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 89. LAMEA RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 90. LAMEA RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 91. LAMEA RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 92. BRAZIL RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 93. BRAZIL RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 94. BRAZIL RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 95. SOUTH AFRICA RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 96. SOUTH AFRICA RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 97. SOUTH AFRICA RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 98. SAUDI ARABIA RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 99. SAUDI ARABIA RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 100. SAUDI ARABIA RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 101. UAE RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 102. UAE RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 103. UAE RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 104. ARGENTINA RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 105. ARGENTINA RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 106. ARGENTINA RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 107. REST OF LAMEA RESPIRATORY MONITORING DEVICES, BY MONITORING DEVICE, 2025-2033 ($MILLION)
  • TABLE 108. REST OF LAMEA RESPIRATORY MONITORING DEVICES, BY INDICATION, 2025-2033 ($MILLION)
  • TABLE 109. REST OF LAMEA RESPIRATORY MONITORING DEVICES, BY END USER ., 2025-2033 ($MILLION)
  • TABLE 110. KONINKLIJKE PHILIPS N.V: KEY EXECUTIVES
  • TABLE 111. KONINKLIJKE PHILIPS N.V: COMPANY SNAPSHOT
  • TABLE 112. KONINKLIJKE PHILIPS N.V: OPERATING SEGMENTS
  • TABLE 113. KONINKLIJKE PHILIPS N.V: PRODUCT PORTFOLIO
  • TABLE 114. KONINKLIJKE PHILIPS N.V: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115. GE HEALTHCARE: KEY EXECUTIVES
  • TABLE 116. GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 117. GE HEALTHCARE: OPERATING SEGMENTS
  • TABLE 118. GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 119. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 120. MEDTRONIC: KEY EXECUTIVES
  • TABLE 121. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 122. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 123. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 124. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 125. SMITHS MEDICAL PLC.: KEY EXECUTIVES
  • TABLE 126. SMITHS MEDICAL PLC.: COMPANY SNAPSHOT
  • TABLE 127. SMITHS MEDICAL PLC.: OPERATING SEGMENTS
  • TABLE 128. SMITHS MEDICAL PLC.: PRODUCT PORTFOLIO
  • TABLE 129. SMITHS MEDICAL PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 130. DRäGERWERK AG AND CO. KGAA: KEY EXECUTIVES
  • TABLE 131. DRäGERWERK AG AND CO. KGAA: COMPANY SNAPSHOT
  • TABLE 132. DRäGERWERK AG AND CO. KGAA: OPERATING SEGMENTS
  • TABLE 133. DRäGERWERK AG AND CO. KGAA: PRODUCT PORTFOLIO
  • TABLE 134. DRäGERWERK AG AND CO. KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 135. WELCH ALLYN, INC.: KEY EXECUTIVES
  • TABLE 136. WELCH ALLYN, INC.: COMPANY SNAPSHOT
  • TABLE 137. WELCH ALLYN, INC.: OPERATING SEGMENTS
  • TABLE 138. WELCH ALLYN, INC.: PRODUCT PORTFOLIO
  • TABLE 139. WELCH ALLYN, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 140. MASIMO: KEY EXECUTIVES
  • TABLE 141. MASIMO: COMPANY SNAPSHOT
  • TABLE 142. MASIMO: OPERATING SEGMENTS
  • TABLE 143. MASIMO: PRODUCT PORTFOLIO
  • TABLE 144. MASIMO: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 145. MGC DIAGNOSTICS CORPORATION: KEY EXECUTIVES
  • TABLE 146. MGC DIAGNOSTICS CORPORATION: COMPANY SNAPSHOT
  • TABLE 147. MGC DIAGNOSTICS CORPORATION: OPERATING SEGMENTS
  • TABLE 148. MGC DIAGNOSTICS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 149. MGC DIAGNOSTICS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 150. VYAIRE MEDICAL INC.: KEY EXECUTIVES
  • TABLE 151. VYAIRE MEDICAL INC.: COMPANY SNAPSHOT
  • TABLE 152. VYAIRE MEDICAL INC.: OPERATING SEGMENTS
  • TABLE 153. VYAIRE MEDICAL INC.: PRODUCT PORTFOLIO
  • TABLE 154. VYAIRE MEDICAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 155. NIHON KOHDEN CORPORATION: KEY EXECUTIVES
  • TABLE 156. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
  • TABLE 157. NIHON KOHDEN CORPORATION: OPERATING SEGMENTS
  • TABLE 158. NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO
  • TABLE 159. NIHON KOHDEN CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL RESPIRATORY MONITORING DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL RESPIRATORY MONITORING DEVICES MARKET
  • FIGURE 3. SEGMENTATION RESPIRATORY MONITORING DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN RESPIRATORY MONITORING DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALRESPIRATORY MONITORING DEVICES MARKET
  • FIGURE 11. RESPIRATORY MONITORING DEVICES MARKET SEGMENTATION, BY BY MONITORING DEVICE
  • FIGURE 12. RESPIRATORY MONITORING DEVICES MARKET FOR PULSE OXIMETERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. RESPIRATORY MONITORING DEVICES MARKET FOR CAPNOGRAPHY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. RESPIRATORY MONITORING DEVICES MARKET FOR SPIROMETERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. RESPIRATORY MONITORING DEVICES MARKET FOR POLYSOMNOGRAPHY (PSG), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. RESPIRATORY MONITORING DEVICES MARKET FOR PEAK FLOW METERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. RESPIRATORY MONITORING DEVICES MARKET FOR GAS ANALYZERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. RESPIRATORY MONITORING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. RESPIRATORY MONITORING DEVICES MARKET SEGMENTATION, BY BY INDICATION
  • FIGURE 20. RESPIRATORY MONITORING DEVICES MARKET FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. RESPIRATORY MONITORING DEVICES MARKET FOR ASTHMA, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. RESPIRATORY MONITORING DEVICES MARKET FOR SLEEP APNOEA, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. RESPIRATORY MONITORING DEVICES MARKET FOR INFECTIOUS DISEASE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. RESPIRATORY MONITORING DEVICES MARKET SEGMENTATION, BY BY END USER .
  • FIGURE 25. RESPIRATORY MONITORING DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. RESPIRATORY MONITORING DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 27. RESPIRATORY MONITORING DEVICES MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 28. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 29. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 30. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 31. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 32. COMPETITIVE DASHBOARD
  • FIGURE 33. COMPETITIVE HEATMAP: RESPIRATORY MONITORING DEVICES MARKET
  • FIGURE 34. TOP PLAYER POSITIONING, 2024
  • FIGURE 35. KONINKLIJKE PHILIPS N.V: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. KONINKLIJKE PHILIPS N.V: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. KONINKLIJKE PHILIPS N.V: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. GE HEALTHCARE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. MEDTRONIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. MEDTRONIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. SMITHS MEDICAL PLC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. SMITHS MEDICAL PLC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. SMITHS MEDICAL PLC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. DRäGERWERK AG AND CO. KGAA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. DRäGERWERK AG AND CO. KGAA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. DRäGERWERK AG AND CO. KGAA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. WELCH ALLYN, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. WELCH ALLYN, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. WELCH ALLYN, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. MASIMO: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. MASIMO: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. MASIMO: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. MGC DIAGNOSTICS CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. MGC DIAGNOSTICS CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. MGC DIAGNOSTICS CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 59. VYAIRE MEDICAL INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 60. VYAIRE MEDICAL INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 61. VYAIRE MEDICAL INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 62. NIHON KOHDEN CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 63. NIHON KOHDEN CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 64. NIHON KOHDEN CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Respiratory Monitoring Devices Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue